AHK-Cu

Alanyl-Histidyl-Lysine Copper Complex

Evidence & Status

  • Preliminary / Experimental
  • Preliminary

At a Glance

A synthetic tripeptide-copper complex structurally related to GHK-Cu, differing by a single amino acid (alanine replacing glycine). Studied in cosmeceutical research for collagen synthesis, skin remodeling, and hair follicle biology, with a more limited evidence base than GHK-Cu.

Plain English

Researchers study AHK-Cu because it is a copper-binding peptide closely related to GHK-Cu — one of the more researched copper peptides found naturally in the body. The two compounds differ by a single amino acid: AHK-Cu has alanine where GHK-Cu has glycine at the N-terminus. This structural difference does not dramatically alter how it binds copper or interacts with skin and tissue proteins, and laboratory studies suggest it may stimulate collagen production and support skin repair through similar pathways. AHK-Cu appears in cosmetic serums and hair growth products, often alongside or interchangeably with GHK-Cu. Most of the published research has been conducted in cell culture systems or small animal models, and independent clinical trials comparing AHK-Cu to placebo in humans are currently limited.

Overview

A synthetic tripeptide-copper complex structurally related to GHK-Cu, in which alanine replaces glycine at the N-terminus (Ala-His-Lys vs Gly-His-Lys). Like GHK-Cu, AHK-Cu coordinates cupric ions through the histidine imidazole and N-terminal amine, forming a stable complex capable of penetrating skin barriers and interacting with extracellular matrix proteins. Primarily studied in cosmeceutical research for collagen synthesis stimulation, hair follicle biology, and skin remodeling. The published evidence base is substantially smaller than GHK-Cu; most available data originates from in vitro assays and manufacturer-sponsored studies.

Research Summary

AHK-Cu has a substantially smaller published evidence base than its structural relative GHK-Cu. Available research — conducted primarily in vitro and in small animal models — suggests stimulation of collagen and elastin synthesis through mechanisms proposed by analogy to GHK-Cu, including growth-factor-mediated effects on hair follicle biology reported in laboratory models. The existing literature is dominated by cosmeceutical industry studies and manufacturer-sponsored in vitro assays. Independent, peer-reviewed, placebo-controlled clinical trials in humans are absent. Until such trials are conducted, AHK-Cu's efficacy relative to GHK-Cu, or relative to vehicle control, cannot be established from the published record.

Research Areas

  • Collagen synthesis
  • Skin remodeling & anti-aging
  • Hair follicle biology
  • Wound healing
  • Antioxidant activity

Safety & Risks

Serious Risks

  • Very limited systemic human safety data; injectable use is without an established safety profile; theoretical copper accumulation at high injectable doses; topical cosmetic use is well-tolerated based on commercial history

Reported Side Effects

  • Topical: mild skin irritation or transient redness (uncommon)
  • Injectable: injection site discomfort
  • Potential copper taste with oral or injectable preparations
United States
Research only; sold legally as cosmetic ingredient (not a drug)
United Kingdom
Research only; permitted as cosmetic ingredient
Australia
Research only; cosmetic use permitted
Canada
Research only; cosmetic use permitted